242 related articles for article (PubMed ID: 22659843)
41. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
42. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
Chen J; Huang X; Li N; Liu B; Ma Z; Ling J; Yang W; Li T
Mol Med Rep; 2020 Dec; 22(6):5113-5124. PubMed ID: 33174044
[TBL] [Abstract][Full Text] [Related]
43. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.
Gordian E; Li J; Pevzner Y; Mediavilla-Varela M; Luddy K; Ohaegbulam K; Daniel KG; Haura EB; Muñoz-Antonia T
PLoS One; 2014; 9(12):e114131. PubMed ID: 25501935
[TBL] [Abstract][Full Text] [Related]
45. A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland.
Kohn EA; Du Z; Sato M; Van Schyndle CM; Welsh MA; Yang YA; Stuelten CH; Tang B; Ju W; Bottinger EP; Wakefield LM
Breast Cancer Res; 2010; 12(5):R83. PubMed ID: 20942910
[TBL] [Abstract][Full Text] [Related]
46. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
47. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
49. Smad3 phosphorylation by cyclin-dependent kinases.
Liu F
Cytokine Growth Factor Rev; 2006; 17(1-2):9-17. PubMed ID: 16289004
[TBL] [Abstract][Full Text] [Related]
50. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
51. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
52. Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts.
Abedini Bakhshmand E; Soltani BM
Biol Chem; 2019 Apr; 400(5):677-685. PubMed ID: 30391930
[TBL] [Abstract][Full Text] [Related]
53. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
54. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells.
Shi Y; Wang X; Xu Z; He Y; Guo C; He L; Huan C; Cai C; Huang J; Zhang J; Li Y; Zeng C; Zhang X; Wang L; Ke Y; Cheng H
J Biol Chem; 2020 Oct; 295(40):13798-13811. PubMed ID: 32737199
[TBL] [Abstract][Full Text] [Related]
55. A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition.
Smith AP; Verrecchia A; Fagà G; Doni M; Perna D; Martinato F; Guccione E; Amati B
Oncogene; 2009 Jan; 28(3):422-30. PubMed ID: 18978814
[TBL] [Abstract][Full Text] [Related]
56. SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.
Lin Q; Chen D; Timchenko NA; Medrano EE
Cell Cycle; 2010 May; 9(9):1684-9. PubMed ID: 20404506
[TBL] [Abstract][Full Text] [Related]
57. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.
Wendt MK; Smith JA; Schiemann WP
J Biol Chem; 2009 Dec; 284(49):34145-56. PubMed ID: 19822523
[TBL] [Abstract][Full Text] [Related]
58. Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells.
Chen HS; Bai MH; Zhang T; Li GD; Liu M
Int J Oncol; 2015 Apr; 46(4):1730-8. PubMed ID: 25647396
[TBL] [Abstract][Full Text] [Related]
59. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
60. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
Lin LC; Hsu SL; Wu CL; Liu WC; Hsueh CM
Cell Signal; 2011 Oct; 23(10):1640-50. PubMed ID: 21664967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]